About 11th Annual Engineering Genes, Vectors, Constructs, and Clones

The demand for high-quality biotherapeutic proteins has never been greater. Many variables still must be considered during the engineering process, including verification and sequence analysis of the gene or protein of interest, codon optimization, vector construction and clone/host selection – a time-consuming and expensive process.

Additionally, protein expression scientists are now exploring new engineering tools including synthetic biology and systems engineering.

Ultimately, these tools must be weighed against traditional expression and production strategies to achieve the desired quantity and quality.

Cambridge Healthtech Institute’s 11th Annual Engineering Genes, Vectors, Constructs, and Clones conference continues the tradition of applying effective engineering strategies for protein expression and production research leading to functional biotherapeutic products.

Learn from seasoned, savvy researchers as they share their real-world experiences, applications and results.